TCRT
TCRT
NASDAQ · Biotechnology

Alaunos Therapeutics Inc

$1.02
-0.07 (-6.42%)
As of Sep 28, 10:45 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +3,922.5% upside
Low Target $36.60
Average Target $41.03
High Target $68.97
Current Price $1.02
Current
$1.02
Target
$41.03
$36.60 $41.03 avg $68.97
Scenario Analysis
Bear Case
$36.60
3,488.2%
Low target
Base Case
$41.03
+3,922.5%
Avg target
Bull Case
$68.97
+6,661.8%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.59
-77.8% from high
52-Week Low
$1.02
+0.0% from low
Target vs 52W High
$41.03
+793.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%